Clinical Trials Browser

Phase 2/3 × Uterine Cervical Neoplasms × lenvatinib × Clear all

NCT07177716 2025-09-17

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

Phase 2/3 Not yet recruiting

Uterine Cervical Neoplasms